106 related articles for article (PubMed ID: 21757343)
41. Discovery of molecular switches that modulate modes of metabotropic glutamate receptor subtype 5 (mGlu5) pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidines.
Sharma S; Kedrowski J; Rook JM; Smith RL; Jones CK; Rodriguez AL; Conn PJ; Lindsley CW
J Med Chem; 2009 Jul; 52(14):4103-6. PubMed ID: 19537763
[TBL] [Abstract][Full Text] [Related]
42. New allosteric modulators of metabotropic glutamate receptor 5 (mGluR5) found by ligand-based virtual screening.
Renner S; Noeske T; Parsons CG; Schneider P; Weil T; Schneider G
Chembiochem; 2005 Apr; 6(4):620-5. PubMed ID: 15744765
[No Abstract] [Full Text] [Related]
43. 3-(Pyridin-2-yl-ethynyl)benzamide metabotropic glutamate receptor 5 negative allosteric modulators: hit to lead studies.
Gilbert AM; Bursavich MG; Lombardi S; Adedoyin A; Dwyer JM; Hughes Z; Kern JC; Khawaja X; Rosenzweig-Lipson S; Moore WJ; Neal SJ; Olsen M; Rizzo SJ; Springer D
Bioorg Med Chem Lett; 2011 Jan; 21(1):195-9. PubMed ID: 21126874
[TBL] [Abstract][Full Text] [Related]
44. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.
Pietraszek M; Sukhanov I; Maciejak P; Szyndler J; Gravius A; Wisłowska A; Płaźnik A; Bespalov AY; Danysz W
Eur J Pharmacol; 2005 May; 514(1):25-34. PubMed ID: 15878321
[TBL] [Abstract][Full Text] [Related]
45. Discovery and structure-activity relationship of 1,3-cyclohexyl amide derivatives as novel mGluR5 negative allosteric modulators.
Zhou H; Topiol SW; Grenon M; Jimenez HN; Uberti MA; Smith DG; Brodbeck RM; Chandrasena G; Pedersen H; Madsen JC; Doller D; Li G
Bioorg Med Chem Lett; 2013 Mar; 23(5):1398-406. PubMed ID: 23357634
[TBL] [Abstract][Full Text] [Related]
46. Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator.
Spear N; Gadient RA; Wilkins DE; Do M; Smith JS; Zeller KL; Schroeder P; Zhang M; Arora J; Chhajlani V
Eur J Pharmacol; 2011 Jun; 659(2-3):146-54. PubMed ID: 21335002
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and optimization of 4,5,6,7-tetrahydrooxazolo[4,5-c]pyridines as potent and orally-active metabotropic glutamate receptor 5 negative allosteric modulators.
Hirose W; Kato Y; Natsutani I; Takata M; Kitaichi M; Imai S; Hayashi S; Arai Y; Hoshino K; Yoshida K
Bioorg Med Chem Lett; 2017 Sep; 27(18):4331-4335. PubMed ID: 28838696
[TBL] [Abstract][Full Text] [Related]
48. Discovery of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator.
Ward SE; Harries M; Aldegheri L; Andreotti D; Ballantine S; Bax BD; Harris AJ; Harker AJ; Lund J; Melarange R; Mingardi A; Mookherjee C; Mosley J; Neve M; Oliosi B; Profeta R; Smith KJ; Smith PW; Spada S; Thewlis KM; Yusaf SP
J Med Chem; 2010 Aug; 53(15):5801-12. PubMed ID: 20614889
[TBL] [Abstract][Full Text] [Related]
49. Isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.
Nakamura M; Kurihara H; Suzuki G; Mitsuya M; Ohkubo M; Ohta H
Bioorg Med Chem Lett; 2010 Jan; 20(2):726-9. PubMed ID: 20005101
[TBL] [Abstract][Full Text] [Related]
50. Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).
Christopher JA; Aves SJ; Bennett KA; Doré AS; Errey JC; Jazayeri A; Marshall FH; Okrasa K; Serrano-Vega MJ; Tehan BG; Wiggin GR; Congreve M
J Med Chem; 2015 Aug; 58(16):6653-64. PubMed ID: 26225459
[TBL] [Abstract][Full Text] [Related]
51. Triazolopyridine ethers as potent, orally active mGlu
Higgins MA; Marcin LR; Christopher Zusi F; Gentles R; Ding M; Pearce BC; Easton A; Kostich WA; Seager MA; Bourin C; Bristow LJ; Johnson KA; Miller R; Hogan J; Whiterock V; Gulianello M; Ferrante M; Huang Y; Hendricson A; Alt A; Macor JE; Bronson JJ
Bioorg Med Chem; 2017 Jan; 25(2):496-513. PubMed ID: 27914948
[TBL] [Abstract][Full Text] [Related]
52. Recent progress in the development of allosteric modulators of mGluR5.
Rodriguez AL; Williams R
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):715-22. PubMed ID: 17987523
[TBL] [Abstract][Full Text] [Related]
53. Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain.
Sasikumar TK; Qiang L; Burnett DA; Greenlee WJ; Li C; Heimark L; Pramanik B; Grilli M; Bertorelli R; Lozza G; Reggiani A
Bioorg Med Chem Lett; 2009 Jun; 19(12):3199-203. PubMed ID: 19433355
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: unexpected 'molecular switch' from a closely related mGlu4 positive allosteric modulator.
Utley T; Haddenham D; Salovich JM; Zamorano R; Vinson PN; Lindsley CW; Hopkins CR; Niswender CM
Bioorg Med Chem Lett; 2011 Dec; 21(23):6955-9. PubMed ID: 22030026
[TBL] [Abstract][Full Text] [Related]
55. Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.
Trabanco AA; Tresadern G; Macdonald GJ; Vega JA; de Lucas AI; Matesanz E; García A; Linares ML; Alonso de Diego SA; Alonso JM; Oehlrich D; Ahnaou A; Drinkenburg W; Mackie C; Andrés JI; Lavreysen H; Cid JM
J Med Chem; 2012 Mar; 55(6):2688-701. PubMed ID: 22352782
[TBL] [Abstract][Full Text] [Related]
56. A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5).
Bach P; Nilsson K; Wållberg A; Bauer U; Hammerland LG; Peterson A; Svensson T; Osterlund K; Karis D; Boije M; Wensbo D
Bioorg Med Chem Lett; 2006 Sep; 16(18):4792-5. PubMed ID: 16839764
[TBL] [Abstract][Full Text] [Related]
57. Efficacy switching SAR of mGluR5 allosteric modulators: highly potent positive and negative modulators from one chemotype.
Sams AG; Mikkelsen GK; Brodbeck RM; Pu X; Ritzén A
Bioorg Med Chem Lett; 2011 Jun; 21(11):3407-10. PubMed ID: 21531137
[TBL] [Abstract][Full Text] [Related]
58. 2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-β1 and activin A signalling.
Ciayadi R; Potdar M; Walton KL; Harrison CA; Kelso GF; Harris SJ; Hearn MT
Bioorg Med Chem Lett; 2011 Sep; 21(18):5642-5. PubMed ID: 21783359
[TBL] [Abstract][Full Text] [Related]
59. Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates.
Stepan AF; Claffey MM; Reese MR; Balan G; Barreiro G; Barricklow J; Bohanon MJ; Boscoe BP; Cappon GD; Chenard LK; Cianfrogna J; Chen L; Coffman KJ; Drozda SE; Dunetz JR; Ghosh S; Hou X; Houle C; Karki K; Lazzaro JT; Mancuso JY; Marcek JM; Miller EL; Moen MA; O'Neil S; Sakurada I; Skaddan M; Parikh V; Smith DL; Trapa P; Tuttle JB; Verhoest PR; Walker DP; Won A; Wright AS; Whritenour J; Zasadny K; Zaleska MM; Zhang L; Shaffer CL
J Med Chem; 2017 Sep; 60(18):7764-7780. PubMed ID: 28817277
[TBL] [Abstract][Full Text] [Related]
60. Discovery and biological evaluation of tetrahydrothieno[2,3-c]pyridine derivatives as selective metabotropic glutamate receptor 1 antagonists for the potential treatment of neuropathic pain.
Nam M; Kim T; Kwak J; Seo SH; Ko MK; Lim EJ; Min SJ; Cho YS; Keum G; Baek DJ; Lee J; Pae AN
Eur J Med Chem; 2015 Jun; 97():245-58. PubMed ID: 25984841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
